S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CSUI Cannabis Suisse Corporation (PK)

0.0246

0.0036 (17.14%)

Nov 15 2024 - Closed

Delayed by 15 minutes

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Cannabis Suisse (PK) (USOTC:CSUI)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Cannabis Suisse (PK) Charts.

Cannabis Suisse (PK) (USOTC:CSUI)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Cannabis Suisse (PK) Charts.

Cannabis Suisse Corporation (PK) News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 15 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Wednesday 2 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 13 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
Wednesday 11 September 2024 (2 months ago) • Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Thursday 22 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-A12G - Registration of securities [Section 12(g)]
Thursday 22 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (6 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 12 January 2024 (10 months ago) • Edgar (US Regulatory)

More Cannabis Suisse Corporation (PK) News Articles

Digital Brand Media and ... (PK)

Fannie Mae (QB)

Elite Pharmaceuticals (QB)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions